OnsiteGene Unveils Handheld 10-Minute PCR Device
OnsiteGene, Inc. has announced the launch of myNAT(tm), a handheld, battery-powered real-time PCR instrument capable of completing a full 40-cycle quantitative PCR run in under 10 minutes and weighing only 350 grams. This device is designed for point-of-care diagnostics, enabling rapid nucleic acid testing outside traditional laboratory settings. The product targets applications in infectious disease detection, genetic testing, and field diagnostics. OnsiteGene positions myNAT as a breakthrough in molecular diagnostics, potentially expanding access to rapid testing in remote or resource-limited environments. The company has not yet disclosed pricing or commercial availability details.
Global Impact
Technologically, myNAT represents a significant miniaturization and speed improvement in PCR, potentially enabling real-time outbreak surveillance in low-infrastructure settings. Economically, it could reduce diagnostic costs per test and shorten turnaround times, benefiting healthcare systems and insurers.
Why this score
Neat Digest rated this story 5.9/10 — Significant tier.
Significant tier: a notable product launch in molecular diagnostics with potential to improve point-of-care testing speed and portability, but still early-stage without confirmed market adoption or regulatory milestones.
Sources on this story
Reported by 1 sources, including:
- Newswise